Professional
Added to YB: 2024-03-06
Pitch date: 2024-03-05
BAX [bullish]
Baxter International Inc.
-47.71%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$10.7B
Pitch Price
$40.81
Price Target
67.00 (+214%)
Dividend
0.19%
EV/EBITDA
8.60
P/E
-11.82
EV/Sales
1.64
Sector
Health Care Equipment and Supplies
Category
special_situation
Show full summary:
Baxter International Inc.: Dialysis Shares Rise on Obesity Drug Data Showing Likely Mild Impact on Kidney Disease Progression
$BAX: Baxter's narrow moat from dialysis & injectable therapies pressured by inflation & weak utilization. Spinoff plans & GLP-1 kidney impact add uncertainty. Upside in '25+ from renegotiated contracts & easing headwinds. High risk, but undervalued at $67 FV on improving profits.
Read full article (10 min)